[Extensive metastatic Kaposi sarcoma in chronic immune suppressed bronchial asthma].
In a severely ill 64-year-old man with multilocular Kaposi sarcoma HIV infection was excluded. The decisive factor in the pathogenesis, was long-term immunosuppression with systemic corticosteroids for bronchial asthma. The patient died from cardiorespiratory insufficiency in the course of tumour progression. Autopsy revealed a vast visceral manifestation of Kaposi sarcoma.
Krüssmann
A
A
Hautklinik Stuttgart Bad Cannstatt.
Goerg
R
R
Laberke
H G
HG
Weidner
F O
FO
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005938:Glucocorticoids; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology; D007165:Immunosuppression Therapy; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000276:immunology / Q000473:pathology / Q000556:secondary*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D012514:Sarcoma, Kaposi / Q000276:immunology* / Q000473:pathology / Q000556:secondary; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000276:immunology* / Q000473:pathology
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D008775:Methylprednisolone
Ausgedehnt metastasiertes Kaposi-Sarkom bei chronisch immunsupprimiertem Bronchialasthma.